首页> 外文期刊>Journal of Breast Cancer >Effect of intracapsular triamcinolone injection in treatment of capsular contracture after augmentation mammoplasty
【24h】

Effect of intracapsular triamcinolone injection in treatment of capsular contracture after augmentation mammoplasty

机译:曲安奈德囊内注射治疗隆乳术后囊膜挛缩的疗效

获取原文
           

摘要

Purpose The main problem for reoperation after augmentation mammoplasty is contraction of the capsule surrounding a breast implant and it tends to be recur after second surgery. The author studied that intracapsular injection of triamcinolone could reduce the recurrence of capsular contracture. Methods Twenty-six cases of capsular contracture, undertaken at the M.D. Clinic between July 2002 and August 2004, were reviewed. Age, types of previous implant, reoperation methods including triamcinolone injection, and recurrence rates were retrospectively evaluated. Results Two cases(7.7%) were in their twenties, 14(53.9%) in their thirties, 7(26.9%) in their forties and 3 (11.5%) in their fifties. The types of previous implant were as followed : 24 (92.3%) saline, 2 (7.7%) silicone gel, 14(53.9%) textured type and 12 (46.1%) smooth type. The reoperation methods were as followed : capsulectomy in 4(15.4%), subpectoral conversion in 1 (3.9%), subpectoral conversion with an intracapsule injection of triamcinolone in 2 (7.7%), capsulotomy in 7 (26.9%) and capsulotomy with an intracapsule injection of triamcinolone in 12 (46.2%). Recurrence occurred in 1 capsulectomy (25%), 1 subpectoral conversion (100%), 0 subpectoral conversion with injection (0%), 4 capsulotomy (57%) and 1 capsulotomy with injection (8.3%). Conclusion The injection of triamcinolone into the capsule following an implant replacement was effective in patients with a capsular contracture after augmentation mammoplasty. It seems to be an effective rational therapy for primary high risk cases with more advanced technique.
机译:目的隆乳术后再手术的主要问题是乳房植入物周围的囊膜收缩,在第二次手术后往往会复发。作者研究了曲安西龙的囊内注射可以减少囊膜挛缩的复发。方法回顾2002年7月至2004年8月在M.D.诊所进行的26例囊膜挛缩症病例。回顾性评估年龄,以前的植入物类型,包括曲安西龙注射液在内的再手术方法和复发率。结果20例年龄在20岁以下的占2%(7.7%),30岁以下的14例(53.9%),40岁以下的7例(26.9%),50岁以下的3例(11.5%)。先前植入物的类型如下:24(92.3%)生理盐水,2(7.7%)硅胶,14(53.9%)纹理型和12(46.1%)光滑型。再次手术的方法如下:囊膜切开术4例(15.4%),胸膜下转化1例(3.9%),囊内注射曲安奈德2例(7.7%)进行胸膜下转化,囊膜切开术7例(26.9%),囊膜切开术2例。曲安奈德胶囊内注射12例(占46.2%)。复发发生在1例囊膜切开术(25%),1例经胸膜下转化术(100%),0例经胸膜下转化术(0%),4例经囊切开术(57%)和1例经囊切开术(8.3%)。结论植入物置换后将曲安西龙注射入胶囊对隆乳术后隆起挛缩的患者有效。对于更先进的技术,它似乎是一种有效的合理治疗方法,适用于原发性高危病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号